Rey R, Sabourin J C, Venara M, Long W Q, Jaubert F, Zeller W P, Duvillard P, Chemes H, Bidart J M
Unité de Recherches sur l'Endocrinologie du Développement (INSERM), Ecole Normale Supérieure, Département de Biologie, Montrouge, France.
Hum Pathol. 2000 Oct;31(10):1202-8. doi: 10.1053/hupa.2000.18498.
Sex cord stromal tumors are gonadal neoplasms containing Sertoli, granulosa, Leydig, or thecal cells, which originate from cells derived from either the sex cords (Sertoli and granulosa cell tumors) or the specific mesenchymal stroma (Leydig and thecal cell tumors) of the embryonic gonad. Only granulosa and Sertoli cells produce anti-Müllerian hormone (AMH). Our purpose was to investigate whether AMH can be used as a specific marker of human granulosa or Sertoli cell origin in gonadal tumors, to distinguish them from other primary or metastatic neoplasms, using immunohistochemistry. We studied 7 juvenile and 6 adult-type granulosa cell tumors of ovarian localization and 3 extraovarian metastases, 20 other ovarian tumors, 6 testicular Sertoli cell tumors, 2 gonadoblastomas, and 13 extragonadal tumors. Granulosa cell tumors, both juvenile- and adult-type of either ovarian or metastatic localization, showed an heterogeneous pattern of AMH immunoreactivity: Areas containing intensely or weakly AMH-positive cells were intermingled with AMH-negative areas. Although in most cases AMH-positive areas represented a minor proportion of tumor cells, we found a positive reaction in all the cases examined. In testes, although normal prepubertal Sertoli cells were intensely positive, testicular Sertoli cell tumors showed large areas of negative reaction, with few positive cells scattered throughout the tumor. AMH was also reactive in most of the cells of sex-cord origin in gonadoblastomas. No AMH immunoreaction was observed in other gonadal and extragonadal tumors. We conclude that AMH expression is conserved in only a small proportion of tumor cells of granulosa or Sertoli cell origin; however, a positive reaction in a few cells helps to distinguish between granulosa or Sertoli cell tumors or gonadoblastomas and other gonadal tumors of different origin.
性索间质肿瘤是一种性腺肿瘤,包含支持细胞、颗粒细胞、间质细胞或卵泡膜细胞,起源于胚胎性腺的性索(支持细胞瘤和颗粒细胞瘤)或特定间充质间质(间质细胞瘤和卵泡膜细胞瘤)衍生的细胞。只有颗粒细胞和支持细胞能产生抗苗勒管激素(AMH)。我们的目的是研究AMH是否可作为性腺肿瘤中人类颗粒细胞或支持细胞起源的特异性标志物,通过免疫组织化学将其与其他原发性或转移性肿瘤区分开来。我们研究了7例卵巢定位的青少年型和6例成人型颗粒细胞瘤以及3例卵巢外转移瘤、20例其他卵巢肿瘤、6例睾丸支持细胞瘤、2例性腺母细胞瘤和13例性腺外肿瘤。颗粒细胞瘤,无论是青少年型还是成人型,无论位于卵巢还是转移部位,均显示出AMH免疫反应的异质性模式:含有强或弱AMH阳性细胞的区域与AMH阴性区域相互交织。尽管在大多数情况下,AMH阳性区域仅占肿瘤细胞的一小部分,但我们在所检查的所有病例中均发现了阳性反应。在睾丸中,尽管青春期前正常支持细胞呈强阳性,但睾丸支持细胞瘤显示大片阴性反应区域,仅有少数阳性细胞散在分布于肿瘤中。AMH在性腺母细胞瘤中大多数性索起源的细胞中也有反应。在其他性腺和性腺外肿瘤中未观察到AMH免疫反应。我们得出结论,AMH表达仅在一小部分颗粒细胞或支持细胞起源的肿瘤细胞中得以保留;然而,少数细胞中的阳性反应有助于区分颗粒细胞瘤或支持细胞瘤或性腺母细胞瘤与其他不同起源的性腺肿瘤。